Bayer AG has agreed to pay the US government US $257 million after it was found guilty of overcharging for its antibiotic drug Cipro. The company admitted to selling Cipro to healthcare provider Kaiser Permanente at a price lower than what it was billing the government-aided Medicaid programme. This action violates a US law that requires drug companies to supply their medicines to Medicaid at the lowest cost to any purchaser.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.